Mode
Text Size
Log in / Sign up
N/A Completed N=43 Randomized Single-blind Prevention

LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care

Source: ClinicalTrials.gov NCT04199052 ↗
Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcomePrimary: Number of HIV Care Visits — 1.00; 3.00 HIV Care Visits

Summary

Investigators will develop and pilot test a culturally tailored, trauma-informed smartphone app, called LinkPositively, for Black WLHA affected by interpersonal violence. The goal is to determine preliminary effects of the intervention on HIV care (i.e., retention in HIV care, ART adherence) and mental health outcomes (e.g., PTSD, depression, anxiety). Through a randomized control trial (RCT), participants will be randomly assigned to either the intervention arm (n=40) or control arm (Ryan White standard of care, n=40), with follow-up at 3- and 6- months. This study will benefit the advancement of HIV prevention science by harnessing technology to promote engagement in HIV care, while improving social support through peers and social networking-all under the auspices of being trauma-informed for Black WLHA with experiences of interpersonal violence.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of HIV Care Visits
2.00; 3.00
PRIMARY
Number of Participants With ART Adherence
3; 7
PRIMARY
HIV Adherence Self-Efficacy
8.21; 9.18
SECONDARY
National Stressful Events Survey PTSD Short Scale Score
10.00; 7.50
SECONDARY
Patient Health Questionnaire for Depression Score
8.50; 6.00
SECONDARY
Generalized Anxiety Disorder Score
8.00; 5.00

Eligibility Criteria

Inclusion Criteria

  • Female Gender
  • Black or African-American racial/ethnic background
  • Aged 18 years or older
  • HIV-positive status
  • Ever experienced physical, sexual, and/or psychological abuse by a current or former partner or non-partner (e.g., relative, friend, stranger)
  • Owner of a smartphone with internet browsing capabilities
  • English speaking

Exclusion Criteria

  • Male Gender
  • Aged 17 or younger
  • HIV-negative status
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04199052). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search